glp-1 regulatory news ๐จ Big for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in The GLP-1 Access Gap: Mapping
Description
In my opinion, this is a miserable return on investment given the billions invested and decades spent chasing tails on the wrong hypotheses
The FDA defines dietary supplements as products that must be swallowed, which means patches technically cannot be considered dietary supplements under federal law
Allergen Information: Contains Milk
Cover Image Credit: Iakovenko / 123RF.com (Licensed)
Rigorous clinical trials are needed to determine whether any observed benefits represent genuine therapeutic effects beyond weight reduction alone
1 Comparison of peptidyl and non-peptidyl glucagon-like peptide-1 (GLP-1) receptor agonists
